Search - tctmd.com

Displaying 1 - 17 of 17

Sort: Relevancy | Date

News Daily News

Coronary CTA Reimbursement for US Hospitals to Double in 2025

Yael L. Maxwell

November 08, 2024

News Daily News

A Simple Nudge Moves the Needle on Statin Prescribing

Michael O'Riordan

December 02, 2022

News Daily News

DELIVER Trial Scores a Win for Dapagliflozin in HFpEF

L.A. McKeown

May 05, 2022

News Daily News

CMS Releases Proposed Updates for Coverage of Transcatheter MV Repair

Todd Neale

July 01, 2020

News Daily News

Cardiology Societies Unite to Condemn Racism and Health Inequality

L.A. McKeown

June 01, 2020

News Daily News

Kawasaki Link to COVID-19 in Kids Probed as UK, New York Issue Alerts

Shelley Wood

May 06, 2020

News Conference News

ACC, EHRA Cancel 2020 Meetings Over COVID-19

Michael O'Riordan

March 09, 2020

News Daily News

FDA Advisors Recommend CVD Event Reduction Claim for Icosapent Ethyl

Michael O'Riordan

November 14, 2019

News Conference News ISET 2019

Paclitaxel in PAD: What to Tell Patients While the Numbers Are Crunched

Caitlin E. Cox

January 28, 2019

News Daily News

SORT-OUT IX: Statistical Mix-up Turns Trial’s Primary Endpoint Around

Michael O'Riordan

November 06, 2018

News Daily News

FDA: Clarithromycin Risks Persist in Patients With CAD

Todd Neale

February 26, 2018

News Features

Absorb in Europe: When, How, and by Whom the Beleaguered BVS Is Being Used After Restrictions

Michael O'Riordan

May 08, 2017

News Daily News

FDA’s Latest Move Against Aspirin for CVD Primary Prevention: A Picture Is Worth 11 Words

Shelley Wood

January 13, 2017

News Daily News

FDA Calls It Quits on Black-Box Warnings for Smoking Cessation Drugs

Shelley Wood

December 20, 2016

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2016

Caitlin E. Cox

September 01, 2016

News Daily News

USPSTF: Not Enough Evidence to Recommend Routine Lipid Screening in Children and Adolescents

Michael O'Riordan

August 09, 2016

News Daily News

Now You See It: FDA Approves Absorb Bioresorbable Scaffold

Michael O'Riordan

July 05, 2016

Advertisement

Coronary CTA Reimbursement for US Hospitals to Double in 2025

A Simple Nudge Moves the Needle on Statin Prescribing

DELIVER Trial Scores a Win for Dapagliflozin in HFpEF

CMS Releases Proposed Updates for Coverage of Transcatheter MV Repair

Cardiology Societies Unite to Condemn Racism and Health Inequality

Kawasaki Link to COVID-19 in Kids Probed as UK, New York Issue Alerts

ACC, EHRA Cancel 2020 Meetings Over COVID-19

FDA Advisors Recommend CVD Event Reduction Claim for Icosapent Ethyl

Paclitaxel in PAD: What to Tell Patients While the Numbers Are Crunched

SORT-OUT IX: Statistical Mix-up Turns Trial’s Primary Endpoint Around

FDA: Clarithromycin Risks Persist in Patients With CAD

Absorb in Europe: When, How, and by Whom the Beleaguered BVS Is Being Used After Restrictions

FDA’s Latest Move Against Aspirin for CVD Primary Prevention: A Picture Is Worth 11 Words

FDA Calls It Quits on Black-Box Warnings for Smoking Cessation Drugs

TCTMD’s Top 10 Most Popular Stories for August 2016

USPSTF: Not Enough Evidence to Recommend Routine Lipid Screening in Children and Adolescents

Now You See It: FDA Approves Absorb Bioresorbable Scaffold

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content